376
|
Peters M, Kauth M, Schwarze J, Körner-Rettberg C, Riedler J, Nowak D, Braun-Fahrländer C, von Mutius E, Bufe A, Holst O. Untersuchung der Wirkung von Stallstaubextrakten im Allergiemodell der Maus. Pneumologie 2006. [DOI: 10.1055/s-2005-925512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
377
|
Hamzei F, Krüger H, Peters M, Weiller C. Videobeobachtung während der Forced use Therapie der unteren Extremität führt zu einem zusätzlichen Benefiz. AKTUELLE NEUROLOGIE 2006. [DOI: 10.1055/s-2006-953105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
378
|
Hamzei F, Krüger H, Peters M, Ketels G, Rijntjes M, Weiller C. Forced use Therapie der unteren Extremität. AKTUELLE NEUROLOGIE 2005. [DOI: 10.1055/s-2005-919480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
379
|
Peters M, Kauth M, Schwarze J, Körner-Rettberg C, Riedler J, Nowak D, Braun-Fahrländer C, von Mutius E, Bufe A, Holst O. Inhalation of stable dust extract prevents allergen induced airway inflammation and hyperresponsiveness. Thorax 2005; 61:134-9. [PMID: 16244088 PMCID: PMC2104583 DOI: 10.1136/thx.2005.049403] [Citation(s) in RCA: 53] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Recent epidemiological studies have shown that growing up on a traditional farm provides protection from the development of allergic disorders such as hay fever and allergic asthma. We present experimental evidence that substances providing protection from the development of allergic diseases can be extracted from dust collected in stables of animal farms. METHODS Stable dust was collected from 30 randomly selected farms located in rural regions of the Alps (Austria, Germany and Switzerland). The dust was homogenised with glass beads and extracted with physiological sodium chloride solution. This extract was used to modulate immune response in a well established mouse model of allergic asthma. RESULTS Treatment of mice by inhalation of stable dust extract during sensitisation to ovalbumin inhibited the development of airway hyperresponsiveness and airway eosinophilia upon challenge, as well as the production of interleukin 5 by splenocytes and of antigen specific IgG(1) and IgE. Dust extract also suppressed the generation of human dendritic cells in vitro. The biological activity of the dust extract was not exclusively mediated by lipopolysaccharide. CONCLUSIONS Stable dust from animal farms contains strong immune modulating substances. These substances can interfere with the development of both cellular and humoral immunity against allergens, thus suppressing allergen sensitisation, airway inflammation, and airway hyperresponsiveness in a murine model of allergic asthma.
Collapse
|
380
|
Rothermundt M, Falkai P, Ponath G, Abel S, Diedrich M, Hetzel G, Peters M, Siegmund A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. PHARMACOPSYCHIATRY 2005. [DOI: 10.1055/s-2005-918821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
381
|
ter Avest PC, Tytgat GAM, Westra M, Peters M, van den Berg M. [Haemolytic anaemia and a clotting disorder as first signs of cystic fibrosis in two infants]. NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE 2005; 149:2125-8. [PMID: 16201604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
2 infants, a boy aged 8 weeks and a girl aged 5 months, presented with symptoms of fat-soluble vitamin deficiencies. The first infant had frequently voluminous bowel movements, anaemia and was not thriving; he had anaemia due to vitamin-E deficiency. The second infant had multiple haematomas on the trunk and legs due to a vitamin-K deficiency-related clotting disorder. The sweat test was positive in both cases, confirming the diagnosis of cystic fibrosis. The infants were treated with supplementary pancreatic enzymes and fat-soluble vitamins A, D, E and K. Cystic fibrosis rarely presents with symptoms of fat-soluble vitamin deficiency. However, in cases of unexplained haemolytic anaemia or haemorrhagic disorder due to vitamin E or K deficiencies, respectively, cystic fibrosis should be considered as a possible cause.
Collapse
|
382
|
Onland W, Böing AN, Meijer AB, Schaap MCL, Nieuwland R, Haasnoot K, Sturk A, Peters M. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family. Haemophilia 2005; 11:539-47. [PMID: 16128900 DOI: 10.1111/j.1365-2516.2005.01137.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We present the clinical, biochemical and genomic findings of a family with congenital factor XIII (FXIII) deficiency. Congenital FXIII deficiency is a very rare autosomal recessive bleeding disorder, characterized by umbilical cord bleeding at birth and spontaneous intracranial haemorrhage. Routine clotting tests are normal, which may delay the diagnosis, leading to an increased chance of severe sequelae. The propositus and her brother, known with haemorrhagic diathesis, were found to be compound heterozygous with a known missense mutation (1050 G --> T transversion in exon 7, Val316Phe substitution) and a novel mutation 889 G --> A in exon 6, which predicts a Gly262Glu substitution. As these mutations were known in the family, DNA obtained from cord blood of the youngest sister was analysed for mutations in exons 6 and 7 only. We postulate that the diagnosis was facilitated by determining the two different mutations in the genotype of this family. The analysis showed that she was heterozygous for the exon 7 mutation. Hence, she was not at risk of experiencing haemorrhagic diathesis. This diagnosis avoided the administration of FXIII concentrate to the newborn.
Collapse
|
383
|
Dowson AJ, Kilminster S, Peters M, Lipscombe S, Rees T, Carter F, Darling S. Understanding the Evidence: Evaluating the Efficacy of Migraine Medications in Clinical Practice. ACTA ACUST UNITED AC 2005. [DOI: 10.1185/174234305x36642] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
384
|
Weitzel T, Mühlberger N, Jelinek T, Schunk M, Ehrhardt S, Bogdan C, Arasteh K, Schneider T, Kern WV, Fätkenheuer G, Boecken G, Zoller T, Probst M, Peters M, Weinke T, Gfrörer S, Klinker H, Holthoff-Stich ML. Imported leishmaniasis in Germany 2001–2004: data of the SIMPID surveillance network. Eur J Clin Microbiol Infect Dis 2005; 24:471-6. [PMID: 15997368 DOI: 10.1007/s10096-005-1363-1] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Leishmaniasis is a rare, non-notifiable disease in Germany. Epidemiological and clinical data, therefore, are scarce. Most infections seen in Germany are contracted outside the country. The German surveillance network for imported infectious diseases (Surveillance Importierter Infektionen in Deutschland, or SIPMID) recorded 42 cases of imported leishmaniasis (16 visceral, 23 cutaneous, and 3 mucocutaneous) from January 2001 to June 2004. Although most infections were acquired in European Mediterranean countries, the risk of infection was highest for travelers to Latin America. HIV coinfection was observed significantly more often in patients with visceral leishmaniasis than in patients with cutaneous/mucocutaneous leishmaniasis (31 vs. 4%, p=0.02). The median time to a definitive diagnosis was 85 days in cases of visceral leishmaniasis and 61 days in cases of cutaneous/mucocutaneous leishmaniasis, reflecting the unfamiliarity of German physicians with leishmanial infections. Visceral leishmaniasis was treated most frequently with amphotericin B, whereas cutaneous/mucocutaneous leishmaniasis was treated with a variety of local and systemic therapies. The findings presented here should serve to increase awareness as well as improve clinical management of leishmaniasis in Germany.
Collapse
|
385
|
van Beers EJ, Peters M, Biemond BJ. [Pathophysiology and treatment of sickle-cell disease]. NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE 2005; 149:1144-9. [PMID: 15940917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Sickle-cell disease is a hereditary haemoglobinopathy caused by a mutation in the beta-globin gene. The disease is characterised by recurrent vaso-occlusive crises resulting in severe organ damage and a sharply reduced life expectancy. The formation of haemoglobin-S polymers in hypoxic conditions plays a pivotal role in sickle-cell disease and produces the characteristic phenotype of sickle-shaped erythrocytes that promote vasoocclusion. Endothelial cell activation, enhanced erythrocyte and leukocyte adhesion, vasoconstriction and coagulation activation play an important role in vaso-occlusive crises. Treatment of pain and hydration remain the main interventions in the management ofvaso-occlusive crises. Hydroxyurea has been shown to prevent vaso-occlusive crises by increasing the amount of foetal haemoglobin. Allogeneic stem-cell transplantation is the only curative therapy. However, transplantation-related mortality, graft-versus-host disease and the limited availability of HLA-identical donors restrict this therapeutic option.
Collapse
|
386
|
Koot BGP, Benninga MA, Weegink CJ, Peters M. [The treatment of chronic hepatitis C virus infection in children]. NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE 2005; 149:832-5. [PMID: 15850275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
A 9-year-old boy, a 15-year-old boy, and a 6-year-old girl were infected with chronic hepatitis C virus (HCV). They had no physical complaints and a virus genotype that was favourable to treatment with peginterferon-alpha and ribavirin. The younger boy and the girl had liver fibrosis and were treated for 6 months; the virus was eradicated from the boy's plasma and the fibrosis diminished, while the girl's plasma virus was again present shortly after the end of treatment. In the older boy with no fibrosis, treatment was temporarily suspended due to behaviour problems. HCV infection is a frequent cause of chronic hepatitis in children. A better understanding of its natural history, improvements in the efficacy of treatment, and more favourable outcomes seen in children compared with adults have gradually changed the consideration to treat children with chronic HCV infection over the last 10 years. The decision whether or not to treat depends primarily on the degree of liver damage, virus genotype, and the psychological condition and motivation of the patient. Screening patients at risk for chronic HCV infection and careful follow-up for liver damage in those with HCV infection have become even more important given the new insights regarding treatment.
Collapse
|
387
|
Prang N, Preithner S, Brischwein K, Göster P, Wöppel A, Müller J, Steiger C, Peters M, Baeuerle PA, da Silva AJ. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines. Br J Cancer 2005; 92:342-9. [PMID: 15655555 PMCID: PMC2361858 DOI: 10.1038/sj.bjc.6602310] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
MT201 is a fully human monoclonal IgG1 antibody with moderate affinity for epithelial cell adhesion molecule (Ep-CAM) being clinically developed for the treatment of carcinomas. Like many other clinically validated IgG1 monoclonal antibodies, MT201 primarily acts by antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). Here, we analysed ADCC and CDC induced by MT201 and, as reference, trastuzumab against a panel of nine human breast cancer cell lines expressing distinct surface levels of Ep-CAM and human epithelial growth factor receptor type 2 antigen. Maximal cell lysis by ADCC by MT201 and trastuzumab in the presence of peripheral mononuclear cells did not significantly differ when averaged over the nine cell lines, but showed marked differences with respect to individual cell lines. The extent of cell lysis at intermediate surface target density was highly variable, suggesting a dominant influence of other susceptibility factors. Only one breast cancer cell line was eliminated via CDC, but only by MT201. Resistance to CDC appeared to correlate with high expression levels of complement resistance factors. Our present data as well as recent data on the prevalence and prognostic relevance of Ep-CAM expression in metastatic breast cancer suggest that Ep-CAM-specific monoclonal IgG1 antibodies may have a significant therapeutic potential in the treatment of breast cancer.
Collapse
|
388
|
Bril WS, MacLean PE, Kaijen PHP, van den Brink EN, Lardy NM, Fijnvandraat K, Peters M, Voorberg J. HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation. Haemophilia 2005; 10:509-14. [PMID: 15357778 DOI: 10.1111/j.1365-2516.2004.01011.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
We evaluated inhibitor formation in a group of patients with mild haemophilia A caused by an Arg593 to Cys mutation. A remarkably high cumulative inhibitor incidence of 14% over 22 years was observed. Three of 49 patients developed transient, low-titre inhibitors, which remained below 2.0 BU mL(-1). Four patients with an Arg593 to Cys mutation developed high-titre inhibitors (>5.0 BU mL(-1)). Three of these patients have been described previously. In this study, we characterized inhibitory antibodies in a fourth patient with high-titre inhibitors. Epitope mapping studies revealed that antibodies were predominantly directed to the A2 domain of factor VIII. We addressed the role of human leucocyte antigen (HLA) class II alleles in inhibitor development in patients with an Arg593 to Cys mutation by HLA genotyping. In the group of inhibitor patients raised frequencies of HLA-DRB1*01 and HLA-DQB1*05 were observed that did not reached statistical significance. Our data suggest that inhibitor development in mild haemophilia A patients with an Arg593 to Cys mutation is not linked to HLA class II profile.
Collapse
|
389
|
Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. The patients' perceptions of migraine and chronic daily headache: a qualitative study. J Headache Pain 2005; 6:40-7. [PMID: 16362190 PMCID: PMC3451956 DOI: 10.1007/s10194-005-0144-7] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2004] [Accepted: 10/19/2004] [Indexed: 12/03/2022] Open
Abstract
This study aimed to gain
insight into the management of
migraine and chronic daily
headache (CDH) from the patients’
perspective. This article outlines
the patients’ perceptions of
migraine and chronic daily
headache. Thirteen semi–structured
interviews were carried out with
patients suffering from IHS
migraine. Five patients, due to their
headache frequency of more than
15 headache days per month, were
classed as CDH patients. The data
were transcribed verbatim and
analysed in accordance with the
grounded theory methodology. The
main themes were: headaches,
impact and headaches related to
health issues. The theme
‘headaches’ was sub-divided into
‘their pain and symptoms’, ‘differentiating
between their headaches’
and ‘perceptions of headaches as
barriers and facilitators to management’.
The patients’ perceptions of
migraine and CDH were sometimes
conflicting and influenced the
patients’ management behaviours.
The qualitative methodology may
help to inform doctors, other
healthcare professionals and
headache researchers about the
patients’ perspective and possibly
develop future headache research,
care and education.
Collapse
|
390
|
Geburek F, Wagels R, Markus R, Kampmann C, Peters M, Stadler P. Ultrasonographic panoramic-imaging as a complement to the clinical and radiographic examination of fractures in the pelvic region in horses. PFERDEHEILKUNDE 2005. [DOI: 10.21836/pem20050601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
391
|
Di Bisceglie AM, Loyet M, Peters M. Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Minerva Med 2004; 95:529-34. [PMID: 15785437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
AIM Osteodystrophy is a well known complication of cholestatic liver diseases such as primary biliary cirrhosis (PBC), although the factors predisposing to the development of metabolic bone disease and its natural history have not been well studied. METHODS We followed a cohort of patients, predominantly post-menopausal females, for changes in bone mineral density over a period of up to 8 years. RESULTS We found that most patients with PBC have relatively stable lumbar bone density over time, even in the face of progressive liver disease. Only 2 of 22 patients experienced fractures. Both of these patients had low initial bone density measurements. CONCLUSIONS We recommend that all patients with newly diagnosed PBC undergo bone mineral density measurement so as to identify those at greatest risk of pathological fractures.
Collapse
|
392
|
Chao Y, Chang P, Abe K, Abe K, Abe N, Adachi I, Aihara H, Akai K, Akatsu M, Akemoto M, Asano Y, Aso T, Aulchenko V, Aushev T, Aziz T, Bahinipati S, Bakich AM, Ban Y, Barbero M, Bay A, Bedny I, Bitenc U, Bizjak I, Blyth S, Bondar A, Bozek A, Bracko M, Brodzicka J, Browder TE, Chang MC, Chen A, Chen KF, Chen WT, Cheon BG, Chistov R, Choi SK, Choi Y, Choi YK, Chuvikov A, Cole S, Danilov M, Dash M, Dong LY, Dowd R, Dragic J, Drutskoy A, Eidelman S, Eiges V, Enari Y, Epifanov D, Everton CW, Fang F, Flanagan J, Fratina S, Fujii H, Funakoshi Y, Furukawa K, Gabyshev N, Garmash A, Gershon T, Go A, Gokhroo G, Golob B, Grosse Perdekamp M, Guler H, Guo R, Haba J, Hagner C, Handa F, Hara K, Hara T, Hastings NC, Hasuko K, Hayasaka K, Hayashii H, Hazumi M, Heenan EM, Higuchi I, Higuchi T, Hinz L, Hojo T, Hokuue T, Hoshi Y, Hoshina K, Hou S, Hou WS, Hsiung YB, Huang HC, Igaki T, Igarashi Y, Iijima T, Ikeda H, Imoto A, Inami K, Ishikawa A, Ishino H, Itoh K, Itoh R, Iwamoto M, Iwasaki M, Iwasaki Y, Kagan R, Kakuno H, Kamitani T, Kang JH, Kang JS, Kapusta P, Kataoka SU, Katayama N, Kawai H, Kawai H, Kawakami Y, Kawamura N, Kawasaki T, Kent N, Khan HR, Kibayashi A, Kichimi H, Kikuchi M, Kikutani E, Kim HJ, Kim HO, Kim H, Kim JH, Kim SK, Kim TH, Kinoshita K, Kobayashi S, Koiso H, Koppenburg P, Korpar S, Krizan P, Krokovny P, Kubo T, Kulasiri R, Kumar S, Kuo CC, Kurashiro H, Kurihara E, Kusaka A, Kuzmin A, Kwon YJ, Lange JS, Leder G, Lee SE, Lee SH, Lee YJ, Lesiak T, Li J, Limosani A, Lin SW, Liventsev D, MacNaughton J, Majumder G, Mandl F, Marlow D, Masuzawa M, Matsuishi T, Matsumoto H, Matsumoto S, Matsumoto T, Matyja A, Michizono S, Mikami Y, Mimashi T, Mitaroff W, Miyabayashi K, Miyabayashi Y, Miyake H, Miyata H, Mizuk R, Mohapatra D, Moloney GR, Moorhead GF, Mori T, Mueller J, Murakami A, Nagamine T, Nagasaka Y, Nakadaira T, Nakamura I, Nakamura TT, Nakano E, Nakao M, Nakayama H, Nakazawa H, Natkaniec Z, Neichi K, Nishida S, Nitoh O, Noguchi S, Nozaki T, Ogawa A, Ogawa S, Ogawa Y, Ohmi K, Ohnishi Y, Ohshima T, Ohuchi N, Oide K, Okabe T, Okuno S, Olsen SL, Onuki Y, Ostrowicz W, Ozaki H, Pakhlov P, Palka H, Park CW, Park H, Park KS, Parslow N, Peak LS, Pernicka M, Perroud JP, Peters M, Piilonen LE, Poluektov A, Ronga FJ, Root N, Rozanska M, Sagawa H, Saigo M, Saitoh S, Sakai Y, Sakamoto H, Sakaue H, Sarangi TR, Satapathy M, Sato N, Schietinger T, Schneider O, Schümann J, Schwanda C, Schwartz AJ, Seki T, Semenov S, Senyo K, Settai Y, Seuster R, Sevior ME, Shibata T, Shibuya H, Shidara T, Shwartz B, Sidorov V, Siegle V, Singh JB, Somov A, Soni N, Stamen R, Stanic S, Staric M, Sugahara R, Sugi A, Sugimura T, Sugiyama A, Sumisawa K, Sumiyoshi T, Suzuki S, Suzuki SY, Swain SK, Tajima O, Takasaki F, Tamai K, Tamura N, Tanabe K, Tanaka M, Tawada M, Taylor GN, Teramoto Y, Tian XC, Tokuda S, Tovey SN, Trabelsi K, Tsuboyama T, Tsukamoto T, Uchida K, Uehara S, Uglov T, Ueno K, Unno Y, Uno S, Ushiroda Y, Varner G, Varvell KE, Villa S, Wang CC, Wang CH, Wang JG, Wang MZ, Watanabe M, Watanabe Y, Widhalm L, Xie QL, Yabsley BD, Yamaguchi A, Yamamoto H, Yamamoto N, Yamamoto S, Yamanaka T, Yamashita Y, Yamauchi M, Yang H, Yeh P, Ying J, Yoshida K, Yoshida M, Yuan Y, Yusa Y, Yuta H, Zang SL, Zhang CC, Zhang J, Zhang LM, Zhang ZP, Zheng Y, Zhilich V, Ziegler T, Zontar D, Zürcher D. Evidence for direct CP violation in B0-->K+pi- decays. PHYSICAL REVIEW LETTERS 2004; 93:191802. [PMID: 15600826 DOI: 10.1103/physrevlett.93.191802] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2004] [Indexed: 05/24/2023]
Abstract
We report evidence for direct CP violation in the decay B0-->K+pi(-) with 253 fb(-1) of data collected with the Belle detector at the KEKB e(+)e(-) collider. Using 275x10(6) BB pairs we observe a B-->K+/-pi(-/+) signal with 2140+/-53 events. The measured CP violating asymmetry is A(CP)(K+pi(-))=-0.101+/-0.025(stat)+/-0.005(syst), corresponding to a significance of 3.9sigma including systematics. We also search for CP violation in the decays B+-->K+pi(0) and B+-->pi(+)pi(0). The measured CP violating asymmetries are A(CP)(K+pi(0))=0.04+/-0.05(stat)+/-0.02(syst) and A(CP)(pi(+)pi(0))=-0.02+/-0.10(stat)+/-0.01(syst), corresponding to the intervals -0.05<A(CP)(K+pi(0))<0.13 and -0.18<A(CP)(pi(+)pi(0))<0.14 at 90% confidence level.
Collapse
|
393
|
Bähr C, Kuiper H, Peters M, Scholz H, Distl O. [Arthrogryposis associated with facial scoliosis and torticollis in German Holstein calves]. DTW. DEUTSCHE TIERARZTLICHE WOCHENSCHRIFT 2004; 111:403-7. [PMID: 15568639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
In 13 German Holstein calves from two different dairy farms arthrogryposis of the front legs, facial scoliosis and torticollis were observed. Obvious environmental reasons could not be found. Chromosomal anomalies in two affected calves were not detectable. A striking feature was the high frequency of affected calves among the offspring of one natural service sire. A plausible explanation of the congenital anomalies observed is a dominantly inherited mutation restricted to germ cells.
Collapse
|
394
|
Rothermundt M, Falkai P, Ponath G, Abel S, Bürkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 2004; 9:897-9. [PMID: 15241436 DOI: 10.1038/sj.mp.4001548] [Citation(s) in RCA: 121] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
395
|
Bruce W, Van der Wall H, Peters M, Morgan L, Hian Liaw Y, Storey G. Novel imaging strategy for the detection of fat embolism after arthroplasty. ANZ J Surg 2004; 74:723-6. [PMID: 15379795 DOI: 10.1111/j.1445-1433.2004.03146.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
INTRODUCTION Respiratory complications are common after arthroplasty with fat emboli and thromboembolic disease (PTE) being the most serious. As fat embolism from bone marrow should contain reticuloendothelial cells, we hypothesized that these cells take up colloid in the lung. A prospective tomographic study of 99m Tc phytate and perfusion was performed within 24 h after arthroplasty. METHODS Tomographic lung studies were acquired after 99m Tc phytate and 99m Tc MAA injection. Pre- and postoperative arterial blood gases (ABG), radiography/computed tomography were obtained. ABG were analysed as the difference in alveolar-arterial oxygen gradients, pre- and postoperatively (D(A-a)). RESULTS Forty patients were studied, 16 with hip and 24 with knee arthroplasties. Lung uptake of 99m Tc phytate was present in 35% of cases. PTE was detected in 25 of 38 (67%) patients evaluated. D(A-a) was significantly different between patients with PTE/fat embolism and without either entity (P < 0.05). CONCLUSION A simple test is available for the detection of fat embolism in the lungs. It can specifically differentiate this common cause of hypoxia from PTE.
Collapse
|
396
|
MacLean PE, Fijnvandraat K, Beijlevelt M, Peters M. The impact of unaware carriership on the clinical presentation of haemophilia. Haemophilia 2004; 10:560-4. [PMID: 15357784 DOI: 10.1111/j.1365-2516.2004.00955.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
This study was conducted to evaluate the effect of an unaware carriership on the delay in diagnosis of haemophilia and the resulting effect of this delay on morbidity. Information on 73 haemophilia patients (<18 years) and their mothers was gathered from data of patients' medical records and completed by interviews with the parent(s). Although a positive family history was present in 52 gravidae, 16 of them (31%) were not aware of their carrier status at moment of delivery. Fifteen of these 16 unaware carriers, were carriers of a non-severe form of haemophilia. In mothers who were unaware of carriership for haemophilia instrumental delivery occurred more frequently than in mothers who knew they were carriers. This is disquieting since instrumental delivery poses a significant risk (relative risk: 17.8, 95% CI: 4.0-78.4) for intra- or extracranial bleedings in newborn haemophiliacs in comparison to spontaneous deliveries or caesarean sections. In 83% of the patients with a positive family history, diagnosis was established before the first bleeding episode. Patients diagnosed by bleedings presented more often with iatrogenic bleedings (38%) then patients who were diagnosed because of a positive family history (9%) (P < 0.05). In comparison to previous studies, more patients had a positive family history and in more haemophiliacs with a positive family history diagnosis was established before the first bleeding episode. Although this reflects the yield of improved diagnostic methods, further reduction of iatrogenic bleeding is possible by intensifying counselling of mild haemophilia carriers.
Collapse
|
397
|
Inwald D, Franklin O, Cubitt D, Peters M, Goldman A, Burch M. Enterovirus myocarditis as a cause of neonatal collapse. Arch Dis Child Fetal Neonatal Ed 2004; 89:F461-2. [PMID: 15321971 PMCID: PMC1721738 DOI: 10.1136/adc.2003.034439] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Seven neonates required intensive care at our institution with enterovirus myocarditis, 2001-2003. Presentation was at a median age of 9 days. All had ischaemic electrocardiograms, poor ventricular function, raised creatine kinase, and enterovirus RNA detected by reverse transcriptase polymerase chain reaction. Four survived. Enterovirus myocarditis may be an under recognised cause of neonatal collapse.
Collapse
|
398
|
Reinalter SC, Jeck N, Peters M, Seyberth HW. Pharmacotyping of hypokalaemic salt-losing tubular disorders. ACTA ACUST UNITED AC 2004; 181:513-21. [PMID: 15283765 DOI: 10.1111/j.1365-201x.2004.01325.x] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
UNLABELLED Long standing confusion exists in the terminology of hypokalaemic salt-losing tubulopathies (SLTs). SLTs are autosomal recessively transmitted and characterized by normotensive secondary hyperreninism/hyperaldosteronism with hypokalaemic metabolic alkalosis. Historically, four phenotypical variants have been described: (1) the (classic) Bartter syndrome (cBS), (2) the hypomagnesaemic hypocalciuric Gitelman syndrome (GS), (3) the hypercalciuric hyperprostaglandin-E-syndrome (HPS) or antenatal Bartter syndrome (aBS) and (4) the hyperprostaglandin-E-syndrome with sensorineural deafness (HPS + SND). The latter two syndromes are the most severe variants with antenatal manifestation with polyhydramnios and life-threatening course of salt- and water-loss. Defects in five renal membrane proteins involved in electrolyte reabsorption have been identified: In HPS-patients mutations in (1) either the furosemide-sensitive sodium-potassium-chloride cotransporter NKCC2, or (2) in the potassium channel ROMK have been identified, and (3) HPS + SND is caused by mutations in the beta-subunit of the chloride channels ClC-Kb and -Ka (named barttin), all mimicking the major pharmacological effects of furosemide with minor potassium-wasting in ROMK-patients as seen in patients treated with simultaneous furosemide and amiloride, and minor calcium-wasting in Barttin-patients resembling the combination of furosemide and thiazides. (4) cBS is caused by mutations in the chloride channel ClC-Kb with similar clinical characteristics as seen under combination of thiazides and furosemide, (5) GS is caused by mutations in the thiazide-sensitive sodium-chloride cotransporter NCCT resembling the effect of long-term thiazide administration. CONCLUSION The combination of pharmacology and genetics suggests a new terminology for the above described SLTs: Furosemide-like-SLT for HPS caused by NKCC2-mutations, furosemide/amiloride-like-SLT for HPS caused by ROMK-mutations, furosemide/thiazide-like-SLT for HPS + SND, thiazide/furosemide-like-SLT for cBS, and thiazide-like-SLT for GS.
Collapse
|
399
|
Nishida S, Abe K, Abe K, Abe T, Aihara H, Asano Y, Aushev T, Bahinipati S, Bakich AM, Ban Y, Banas E, Bay A, Bitenc U, Bizjak I, Blyth S, Bondar A, Bozek A, Bracko M, Brodzicka J, Browder TE, Chang MC, Chang P, Chen KF, Cheon BG, Chistov R, Choi SK, Choi Y, Chuvikov A, Cole S, Danilov M, Dash M, Dong LY, Dragic J, Eidelman S, Eiges V, Enari Y, Epifanov D, Fang F, Fratina S, Garmash A, Gershon T, Gokhroo G, Golob B, Haba J, Hara T, Hastings NC, Hayashii H, Hazumi M, Higuchi T, Hinz L, Hoshi Y, Hou WS, Hsiung YB, Iijima T, Inami K, Ishikawa A, Ishino H, Itoh R, Iwasaki M, Iwasaki Y, Kang JH, Kang JS, Kapusta P, Kataoka SU, Katayama N, Kawasaki T, Kichimi H, Kim HJ, Kim SK, Kim TH, Koppenburg P, Korpar S, Krizan P, Krokovny P, Kuzmin A, Kwon YJ, Lange JS, Leder G, Lee SE, Lee SH, Li J, Lin SW, MacNaughton J, Majumder G, Mandl F, Matsumoto T, Matyja A, Mitaroff W, Miyake H, Mizuk R, Mohapatra D, Moloney GR, Murakami A, Nagamine T, Nagasaka Y, Nakano E, Nakao M, Nakazawa H, Natkaniec Z, Nitoh O, Nozaki T, Ogawa S, Ohshima T, Okabe T, Okuno S, Olsen SL, Ozaki H, Pakhlov P, Palka H, Park CW, Park H, Peters M, Piilonen LE, Ronga FJ, Rozanska M, Sakai Y, Schneider O, Schümann J, Schwanda C, Semenov S, Seuster R, Sevior ME, Shibuya H, Shwartz B, Somov A, Soni N, Stamen R, Stanic S, Staric M, Sugiyama A, Sumiyoshi T, Suzuki S, Tajima O, Takasaki F, Tamai K, Tanaka M, Teramoto Y, Tomura T, Trabelsi K, Tsuboyama T, Tsukamoto T, Uehara S, Uglov T, Ueno K, Unno Y, Uno S, Ushiroda Y, Varner G, Varvell KE, Wang CH, Wang MZ, Watanabe Y, Yabsley BD, Yamada Y, Yamaguchi A, Yamashita Y, Yamauchi M, Yang H, Ying J, Zhang ZP, Zhilich V, Ziegler T, Zontar D, Zürcher D. Measurement of the CP asymmetry in B-->Xs gamma. PHYSICAL REVIEW LETTERS 2004; 93:031803. [PMID: 15323814 DOI: 10.1103/physrevlett.93.031803] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2004] [Indexed: 05/24/2023]
Abstract
Direct CP violation in the b-->sgamma process is a sensitive probe of physics beyond the standard model. We report a measurement of the CP asymmetry in B-->X(s)gamma, where the hadronic recoil system X(s) is reconstructed using a pseudoreconstruction technique. In this approach there is negligible contamination from b-->dgamma decays, which are expected to have a much larger CP asymmetry. We find A(CP)=0.002+/-0.050(stat)+/-0.030(syst) for B-->X(s)gamma events having recoil mass smaller than 2.1 GeV/c(2). The analysis is based on a data sample of 140 fb(-1) recorded at the upsilon(4S) resonance with the Belle detector at the KEKB e(+)e(-) storage ring.
Collapse
|
400
|
Peters M, Dasilva A, Weckermann D, Oberneder R, Ebner B, Kirchinger P, Fetter A, Köhne-Volland R, Baeuerle P, Gjorstrup P. Phase I study of the novel fully human monoclonal antibody MT201, directed against epithelial cellular adhesion molecule (Ep-CAM), in patients with hormone-refractory prostate cancer (HRPC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.2600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|